Share:
LOS ANGELES, May 19, 2021 (GLOBE NEWSWIRE) The
Global Blood Plasma Derivatives Market is expected to grow at a CAGR of around 9.5% from 2020 to 2027 and reach the market value of over US$ 50.3 Bn by 2027.
North America is expected to dominate the global blood plasma derivatives market, followed by Europe. The market in North America is being driven by rising awareness about the use and availability of plasma derivatives for the treatment of infectious diseases. Europe is the second-largest market for blood plasma derivatives after the United States. Advanced research on safe blood transfusion conducted by various health care institutes fuels the market s growth in Europe.